Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...

Mental illness cost Imtiaz Zafar almost a decade of his academic life. Now it motivates him to help find effective treatments ...

Objectives The association between smoking and patients with schizophrenia has been established through epidemiological ...

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an ...

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets ...

--Evoke Pharma, Inc., a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases with an emphasis on GIMOTI ® nasal spray, today announced that it has ...

Loxapine may be effective for the treatment of schizophrenia but does not differ greatly from the older typical antipsychotics (chlorpromazine, trifluperazine, perphenazine) or other atypicals ...